1 service · 14 calls/30d · aeml-x402.zeabur.app
aeml-x402.zeabur.app
[3-LEG] Drug shortage chain, one therapeutic class (?entity=oncology): leading new-shortage incidence from openFDA new listings, which leads the burden peak -> current current active shortages in the class -> realized resolution rate (confirmation gate). A sequential chain, not one reading - confidence = how many legs are lit, in order. Sources: openFDA. Descriptive only, never a forecast or advice. No data -> 422 no_charge, not billed.
